Hjem › Alzheimers sykdom › Illinois
Kliniske studier for Alzheimers sykdom i Illinois
19 studier for Alzheimers sykdom søker deltakere på steder i Illinois.
Byer i Illinois
Offisiell studietekst (engelsk)
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
- Essential Concepts Research Solutions (ECRS), Palos Hills
RekruttererFase 4
Alder 50 og eldre · Alle kjønn · Oppdatert 25. sep. 2026 · NCT07633470Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- RE:Cognition (Chicago), Chicago
- Great Lakes Clinical Trials Chicago d/b/a Flourish Research Andersonville, Chicago
RekruttererFase 3
Alder 50 til 90 · Alle kjønn · Oppdatert 21. sep. 2026 · NCT07177352A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
- Great Lakes Clinical Trials - Andersonville, Chicago
- Southern Illinois University School of Medicine, Springfield
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 17. sep. 2026 · NCT06976203OTC Hearing Aid and MCI
- Northwestern University HA Lab, Evanston
Rekrutterer
Alder 60 til 90 · Alle kjønn · Oppdatert 4. sep. 2026 · NCT06112860A Clinical Study of MK-2214 in People With Early Alzheimer's Disease (MK-2214-004)
- Alexian Brothers Medical Center-Neurosciences ( Site 1017), Elk Grove Village
RekruttererFase 2
Alder 50 til 85 · Alle kjønn · Oppdatert 26. aug. 2026 · NCT07033494A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
- Re:Cognition Health - Chicago, Chicago
- Ascension Alexian Brothers, Elk Grove Village
RekruttererFase 3
Alder 60 til 85 · Alle kjønn · Oppdatert 20. aug. 2026 · NCT06976216Central Auditory Processing Modulation Underlying Anxiety Reduction Using Clinically Designed Improvisatory Music
- Northwestern University Feinberg School of Medicine, Chicago
Rekrutterer
Alder 55 og eldre · Alle kjønn · Oppdatert 20. aug. 2026 · NCT07775625Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant
- John H. Stroger, Jr. Hospital of Cook County, Chicago
- University of Chicago - Medical Center, Chicago
RekruttererFase 3
Alder 18 til 75 · Alle kjønn · Oppdatert 4. aug. 2026 · NCT06563895A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT06647498A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
- Advocate Lutheran General Hospital, Park Ridge
RekruttererFase 2/3Frivillige helsepersonell ønskes velkommen
Alder 18 og eldre · Alle kjønn · Oppdatert 27. jul. 2026 · NCT05552157Development of a Home Test for Measuring Blood P-tau217 in Alzheimer's Disease Using the Tasso Lancet Device
- Insigth Hospital and Medical Center Chicago, Chicago
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 40 til 90 · Alle kjønn · Oppdatert 14. jul. 2026 · NCT07701161A Study of Donanemab (LY3002813) in Participants Who Completed Study AACM (TRAILBLAZER-ALZ 3-EXT).
- Great Lakes Clinical Trials - Andersonville, Chicago
RekruttererFase 3
Alder 55 og eldre · Alle kjønn · Oppdatert 7. jul. 2026 · NCT07602582Communication Bridge 3 Study
- University of Chicago - American School Building, Chicago
RekruttererFase 2
Alder 18 til 100 · Alle kjønn · Oppdatert 1. jun. 2026 · NCT06191198Trial-Ready Cohort-Down Syndrome (TRC-DS)
- Advocate Medical Group Adult Down Syndrome Center, Park Ridge
RekruttererObservasjonsstudie
Alder 25 til 55 · Alle kjønn · Oppdatert 18. mai 2026 · NCT04165109Late Onset Alzheimer's Disease
- Rush University, Aurora
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 55 og eldre · Alle kjønn · Oppdatert 18. mai 2026 · NCT05010603Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Flourish Research - Chicago, Chicago
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 60 til 90 · Alle kjønn · Oppdatert 15. apr. 2026 · NCT06584357Visualizing Brain Proteinopathies Using [F-18]Flornaptitril-PET in the Prediction of Clinical Progression of Mild Cognitive Impairment With Either Suspected Chronic Traumatic Encephalopathy or Alzheimer's Disease
- Endeavor Health Systems, Evanston
RekruttererFase 3Frivillige helsepersonell ønskes velkommen
Alder 45 og eldre · Alle kjønn · Oppdatert 30. jul. 2025 · NCT06254469Feasibility of Using the Gatorade Sports Science Institute (GSSI) Labs App for Hydration Related Outcomes
- Advanced Personalized Ideation Center (API) and Gatorade Sports Science Institute (GSSI), PepsiCo Global R&D - Life Sciences, Chicago
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
Alder 18 til 65 · Alle kjønn · Oppdatert 5. jun. 2025 · NCT07005895Alzheimer's National Registry for Treatment and Diagnostics(ALZ-NET)
- Full List of Active Sites, Chicago
RekruttererObservasjonsstudie
Alder 18 og eldre · Alle kjønn · Oppdatert 14. des. 2023 · NCT06170268Fra ClinicalTrials.gov, data hentet 5. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.